Insight Genetics gets $1.5M boost for lung cancer test

08/27/2013 | GenomeWeb Daily News (free registration)

Insight Genetics will use a $1.5 million grant from the National Cancer Institute to further develop its nonsmall-cell lung cancer diagnostic test. Specifically, Insight said it will develop a panel of tests for detecting and characterizing oncogenic DEPDC1, RET and ROS1 in NSCLC patients who have tested triple negative for KRAS, EGFR or ALK gene mutations.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID